Series B · Healthtech
Evvy raises $40 million to expand microbiome research
Its at-home test uses metagenomic sequencing to analyze hundreds of bacteria and fungi from a vaginal swab.
A broader view of the vaginal microbiome
Customers collect a swab at home and send it to Evvy’s lab for sequencing. The test analyzes hundreds of bacteria and fungi, then returns clinician-reviewed results and a personalized plan for next steps.
Turning test data into research
Evvy invites customers to contribute anonymized data to research on the vaginal microbiome and related conditions. The company is extending that research into additional areas of women’s health, including fertility.
Funding history
Series B · This round$40M